IP Library › Granted Patent US 11,950,896
Granted Patent B2
US 11,950,896 · App. 16/856,100 · Granted Apr 9, 2024

Blood glucose tracking system

Inventor: Arnold Chase (West Hartford, CT)
A61B5/0507A61B5/0004A61B5/14532A61B5/1495A61B5/6824A61B5/7246A61B5/742A61B2562/0228
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,950,896
App. No.
16/856,100
Granted
Apr 9, 2024
Kind
B2
Abstract

A blood glucose tracking system and method measures emitted microwave energy transmitted to and accepted by blood vessels in a desired target area of a patient in order to determine, in real time and in vivo, appropriate blood glucose levels. A measurement unit comprises a transmitter operatively connected to an antenna to deliver energy towards appropriate subcutaneous blood vessels. The measurement unit determines an accepted energy power value in the blood vessels associated with the desired target area. This measurement energy power value is compared with a calibration value, and the difference is used to determine a resultant blood glucose value. The determined blood glucose value may further be acclimatized using additional sensed values compensating for biological and ambient factors relevant to the patient. The final determined blood glucose value can be displayed for reading and/or transmitted and stored for recording for further reference.

Claims (34)

1. A blood glucose measurement device comprising:

an antenna housing having an antenna assembly disposed therein, said antenna housing being adapted for placement on or near a patient's skin proximate to a desired target area comprising blood vessels to be measured, and said antenna assembly comprising an antenna;

a transmitter operatively connected to the antenna for transmitting microwave energy into the blood vessels of the target area via the antenna; and

a controller operatively connected to the transmitter;

wherein controller is configured to:

establish a calibration value of microwave energy absorption by blood located within blood vessels that are within the target area;

determine a measurement value based on an amount of energy transmitted by the transmitter and absorbed by blood vessels in the target area;

compare the calibration value with the measurement value to determine a calculated power differential value; and

determine a blood glucose value representative of the calculated power differential value.

2. The blood glucose measurement device according to claim 1 , wherein the controller is configured to identify a difference between the calibration value and the measurement value for determining the calculated power differential value.

3. The blood glucose measurement device according to claim 1 , wherein the blood vessels in the target area are subcutaneous blood vessels.

4. The blood glucose measurement device according to claim 1 , wherein the measurement device is adapted to be placed on the patient's arm proximate the target area.

5. The blood glucose measurement device according to claim 4 , wherein the measurement device is adapted to be placed on the patient's wrist.

6. The blood glucose measurement device according to claim 4 , further comprising a strap to which the antenna housing is attached, said strap being adapted to be wrapped around the patient's arm.

7. The blood glucose measurement device according to claim 1 , further comprising a visual display for displaying measurement data corresponding to the absorbed microwave energy measurement value.

8. The blood glucose measurement device according to claim 1 , further comprising a second transmitter for transmitting measurement data to an external device for at least one of display and storage of the measurement data.

9. The blood glucose measurement device according to claim 1 , wherein the microwave energy is in the form of microwave pulses.

10. The blood glucose measurement device according to claim 1 , wherein the controller is configured to determine actual energy power levels delivered to the blood vessels in the target area from the antenna assembly.

11. The blood glucose measurement device according to claim 1 , wherein the controller is configured to determine reflected energy power levels delivered to the blood vessels in the target area.

12. The blood glucose measurement device according to claim 1 , wherein the controller is configured to determine a standing wave ratio reading representative of energy absorption in the blood vessels in the target area.

13. A blood glucose measurement device comprising:

an antenna housing having an antenna assembly disposed therein and comprising an antenna;

a transmitter operatively connected to the antenna for transmitting microwave energy into blood vessels of a target area via the antenna; and

a controller operatively connected to the transmitter;

wherein controller is configured to:

establish a calibration value of microwave energy absorption by blood located within blood vessels that are within the target area;

determine a measurement value based on an amount of energy transmitted by the transmitter and absorbed by blood vessels in the target area;

compare the calibration value with the measurement value to determine a calculated power differential value; and

determine a blood glucose value representative of the calculated power differential value.

14. The blood glucose measurement device according to claim 13 , wherein the controller is configured to vary a transmission frequency of the microwave wave energy within a predetermined frequency range.

15. The blood glucose measurement device according to claim 13 , wherein the blood vessel in the target area is a subcutaneous blood vessel.

16. The blood glucose measurement device according to claim 13 , further comprising an individualized radio frequency mask that is transmissive only in a precise area that correlates to the size, shape and location of the blood vessels.

17. The blood glucose measurement device according to claim 13 , wherein the antenna housing is adapted to be located on a patient's wrist, arm, ankle, or other bodily location that has blood vessels in close proximity to the skin's surface.

18. The blood glucose measurement device according to claim 13 , further comprising a display, wherein the controller is configured to cause the display to display the determined blood glucose value.

Continuity (3)
Division 16118827 · Aug 31, 2018
Provisional Application 62646510 · Mar 22, 2018
Related Publication 20200245892A1 · Aug 6, 2020